# Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

> **NCT00935831** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 12 (actual)

## Conditions studied

- Kidney Disease

## Interventions

- **DRUG:** GSK1278863A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00935831
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-12
- **Primary completion:** 2010-04-27
- **Final completion:** 2010-04-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935831, "Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00935831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*